Black Rock Inc. Viking Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,026,131 shares of VKTX stock, worth $402 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,026,131

Previous 8,274,174 27.17%

Holding current value

$402 Million

Previous $678 Million 52.92%

% of portfolio

0.01%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$47.39 - $80.2 $107 Million - $180 Million	-2,248,043 Reduced 27.17%	6,026,131 $319 Million
Q1 2024 May 10, 2024	BUY	$17.4 - $94.5 $11.6 Million - $63.2 Million	668,307 Added 8.79%	8,274,174 $678 Million
Q4 2023 Feb 13, 2024	BUY	$9.24 - $19.64 $4.39 Million - $9.33 Million	474,950 Added 6.66%	7,605,867 $142 Million
Q3 2023 Nov 13, 2023	BUY	$10.92 - $16.0 $2.58 Million - $3.78 Million	235,994 Added 3.42%	7,130,917 $78.9 Million
Q2 2023 Aug 11, 2023	BUY	$14.84 - $24.79 $72 Million - $120 Million	4,854,645 Added 237.94%	6,894,923 $112 Million
Q1 2023 May 12, 2023	BUY	$8.08 - $17.33 $5.61 Million - $12 Million	694,265 Added 51.58%	2,040,278 $34 Million
Q4 2022 Feb 13, 2023	SELL	$2.72 - $9.4 $327,060 - $1.13 Million	-120,243 Reduced 8.2%	1,346,013 $12.7 Million
Q3 2022 Nov 14, 2022	BUY	$2.55 - $3.89 $99,539 - $151,846	39,035 Added 2.74%	1,466,256 $3.99 Million
Q2 2022 Aug 12, 2022	SELL	$2.11 - $3.15 $7.85 Million - $11.7 Million	-3,720,240 Reduced 72.27%	1,427,221 $4.12 Million
Q1 2022 May 12, 2022	BUY	$3.0 - $4.88 $83,913 - $136,498	27,971 Added 0.55%	5,147,461 $15.4 Million
Q4 2021 Feb 10, 2022	SELL	$4.6 - $6.72 $7,557 - $11,040	-1,643 Reduced 0.03%	5,119,490 $23.5 Million
Q3 2021 Nov 09, 2021	SELL	$5.58 - $7.04 $663,556 - $837,175	-118,917 Reduced 2.27%	5,121,133 $32.2 Million
Q2 2021 Aug 11, 2021	BUY	$5.19 - $6.73 $27.2 Million - $35.3 Million	5,240,050 New	5,240,050 $31.4 Million

Others Institutions Holding VKTX

# of Institutions

442

Shares Held

63.3M

Call Options Held

6.23M

Put Options Held

2.97M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $5.12B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account